← Back to Search

Ultrasound for Kidney Stones

N/A
Recruiting
Led By Thomas Chi, M.D.
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial is testing how well ultrasound works to find kidney stone fragments, compared to the current standard (fluoroscopy).

Eligible Conditions
  • Kidney Stones
  • Ultrasound Therapy Complications

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnostic accuracy detecting residual fragments during retrograde intrarenal surgery
Secondary outcome measures
Negative predictive value detecting residual fragments during retrograde intrarenal surgery
Operative time in minutes
Positive predictive value detecting residual fragments during retrograde intrarenal surgery
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: UltrasoundExperimental Treatment1 Intervention
Before completing retrograde intrarenal surgery, a complete endoscopic examination will be performed along with ultrasound by the same endourologist to determine the size of the largest residual fragment.
Group II: FluoroscopyActive Control1 Intervention
Standard of care, control Before completing retrograde intrarenal surgery, a complete endoscopic examination will be performed along with fluoroscopy by the same endourologist to determine the size of the largest residual fragment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~1950

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,500 Previous Clinical Trials
15,236,299 Total Patients Enrolled
1 Trials studying Kidney Stones
3,299 Patients Enrolled for Kidney Stones
Thomas Chi, M.D.Principal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Ultrasound Clinical Trial Eligibility Overview. Trial Name: NCT05535816 — N/A
Kidney Stones Research Study Groups: Ultrasound, Fluoroscopy
Kidney Stones Clinical Trial 2023: Ultrasound Highlights & Side Effects. Trial Name: NCT05535816 — N/A
Ultrasound 2023 Treatment Timeline for Medical Study. Trial Name: NCT05535816 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment currently active for this clinical experiment?

"The information hosted on clinicaltrials.gov suggests that this research endeavour is no longer actively recruiting participants. This investigation, which was initially advertised on the 11th of November in 2022, has not been updated since September 6th of the same year. Nevertheless, there are other 92 studies still searching for volunteers at present day."

Answered by AI
~86 spots leftby Apr 2025